Eurofins Scientific Sa (ERFSF) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day, ladies and gentlemen. Welcome and thank you for joining Eurofin's first quarter 2026 trading update conference call. Please note that this call is being recorded and will later be available for replay on Eurofin's investor relations website. Throughout today's presentation, all participants will be in a listen-only mode. The presentation will be followed by a question and answer session. If you would like to ask a question, you may press a star followed by one on your touchtone telephone to register for questions. For operator assistance, please press the star key followed by zero. During this call, Eurofins management may make forward-looking statements, including but not limited to statements with respect to Outlook and the related assumptions. Management will also discuss alternative performance measures, such as organic growth and EBITDA, which are defined in the footnotes of our press release. Actual results may differ materially from objectives discussed. Risks and uncertainties that may affect Eurofin's future results include, but are not limited to, those described in the risk factors section of the most recent Eurofin's annual and half-year reports. Please also read the disclaimer on page 2 of this presentation, subject to which this call and the Q&A session are made. I would now like to turn the conference over to Dr. Gilles Martin, Eurofins Chief Executive Officer. Please go ahead. Hello, everybody, and welcome to our quarterly call. So in the first quarter and the third quarter, we only publish sessions. It's a limited comment that I will make today. In Q1, what a continuation of last year, we've had a softer revenue growth with a big impact on weather. Those who live in North America, in the Midwest or the East Coast, and even in the South will...